FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update
Starts On:
Fri, 3/4/22: 12:00 AM EST
Ends On:
Tue, 12/31/24: 12:00 AM EST
Type:
Enduring Material
Credits:
1
Description:
This webinar discussed how the Office of Orphan Products Development (OOPD) advances the development of products for rare diseases. The webinar also reviewed the history of OOPD, the Orphan Drug Act, and other core programs within OOPD.
Objectives:
- Describe the mission of Office of Orphan Products Development (OOPD).
- Define rare disease in accordance with the Orphan Drug Act.
- Identify the incentives associated with orphan drug designation.
Additional Information:
Review the Activity Announcement for additional details: Announcement Form
Additional Resources: OrphanProductsDevelopmentSlides
Additional Resources: OrphanProductsDevelopmentSlides